PFDD: Draft guidance seeks to demystify clinical outcomes assessments

Regulatory NewsRegulatory NewsClinical TrialsCombination products/companion diagnosticsDiagnostics/IVDsMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy